tradingkey.logo
搜索

Apimeds Pharmaceuticals US Inc

APUS
添加自选
1.810USD
-0.040-2.16%
交易中 09/23, 09:30美东
2.73M总市值
亏损市盈率 TTM

关于 Apimeds Pharmaceuticals US Inc 公司

Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.

Apimeds Pharmaceuticals US Inc 简介

公司代码APUS
公司名称Apimeds Pharmaceuticals US Inc
上市日期May 09, 2025
CEOMenon (Vin)
员工数量2
证券类型Ordinary Share
年结日May 09
公司地址100 Matawan Road
城市MATAWAN
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编07747
电话18482015010
网址https://www.apimedsus.com/
公司代码APUS
上市日期May 09, 2025
CEOMenon (Vin)

Apimeds Pharmaceuticals US Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President
President
75.00K
--
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President
President
75.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
61.54K
-4.63%
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol A. O'Donnell
Ms. Carol A. O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Dr. Vin Menon
Dr. Vin Menon
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Sungjoon Chae
Mr. Sungjoon Chae
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol A. O'Donnell
Ms. Carol A. O'Donnell
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President
President
75.00K
--
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President
President
75.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
61.54K
-4.63%
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol A. O'Donnell
Ms. Carol A. O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--

常见问题

Apimeds Pharmaceuticals US Inc的前五大股东是谁?

Apimeds Pharmaceuticals US Inc 的前五大股东如下:Mr. Erik C. Emerson
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有